Annual Report for the Financial Year 2025-26

What’s Unlocking the Inside Growth Corporate Horizon Overview 02 A New Chapter in Our Growth Journey 04 About Patel Chem Specialities 06 Our Suite of Products 08 Our Journey of Progress 01 10 Performance Indicators We see the next phase of our 12 From the Chairman & Managing journey as an opportunity to build Director’s Desk greater depth, scale and relevance 14 Building a Stronger Manufacturing across the business. The Foundation foundation we have established 16 Our Growth Strategy for the Future over the years provides us 17 Our Leadership with the confidence to pursue 18 Corporate Information opportunities with a broader perspective, while remaining attentive to the evolving needs of the markets and customers we serve. Our focus is on translating our capabilities into meaningful and sustainable progress. Statutory As we move forward, we will continue to evolve with the Report industry by strengthening what we do well and exploring avenues that can expand our relevance. This includes 20 Notice building deeper capabilities, broadening our market presence 32 Board’s Report and creating greater value through a sharper understanding 53 Management of customer needs. We believe that sustained growth will Discussion and Analysis come from the ability to combine scale with agility, quality with consistency and ambition with disciplined execution. Our aspiration is to grow into a stronger and more competitive organisation, with the capabilities to earn greater customer preference and participate meaningfully across a wider global landscape. By continuing to invest in our strengths and embracing new opportunities, we aim to create a business that is not only larger in scale, but also stronger in capability, Financial relevance and long-term potential. Statements 03 64 Independent Auditor’s Report 75 Notes forming part of the Financial Statements Patel Chem Specialities Limited CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS A New Chapter in Our Growth Journey Our listing on the BSE Our IPO at a Glance marks an important milestone in our evolution, strengthening our financial ₹58.80 70 Crore Lakh Shares and strategic platform for the next phase of Issue Size Fresh Issue growth. The successful completion of our Initial Public Offering provides ₹82-84 ₹84 us with greater visibility and access to capital, Price Band per Share Issue Price supporting our plans to enhance manufacturing 1 August 2025 capabilities, expand our capacity and pursue emerging opportunities BSE Listing Date across our markets. 2 ANNUAL REPORT FY2025-26 ANNUAL REPORT FY2025-26 3 Patel Chem Specialities Limited CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS About Patel Chem Specialities Key Highlights Strengths That Drive Our Advantage Established in 2008, Patel domestic and international Chem Specialities Limited is markets, with its products 20+ 1 Trusted Manufacturing 5 Technical Expertise – engaged in the manufacture reaching more than 20+ Vision Excellence – Qualified professionals and R&D of pharmaceutical excipients countries. Its in-house Strong manufacturing capabilities supporting product Year of Experience and specialty chemicals, R&D and technical team To be a global leader in innovative, capabilities and a high rate of development and technical with its portfolio serving supports the development high-quality pharmaceutical repeat orders. excellence. applications across the of customised and niche excipients, committed to pharmaceutical, food products aligned with sustainability and strong client 2 Capacity for the Future – 6 Customised Solutions – & beverage, cosmetics specific applications and partnerships that enhance drug Main Products Upcoming expansion Proven expertise in developing safety, efficacy, and quality of life and industrial sectors. customer specifications. to enhance production pharmaceutical excipients worldwide. 137 The Company’s products Supported by an expanding capabilities and support tailored to specific customer support diverse formulation manufacturing platform, innovation. requirements. requirements, including the Company is focused Total Employees binding, disintegration, on strengthening its 3 Customer-Centric Approach – 7 Quality-Driven Portfolio – 200+ Responsive technical support International-standard quality thickening, stabilisation and capabilities, broadening Mission and a flexible approach aligned with competitive pricing across other functional applications. its market presence and with evolving customer diverse applications and building a stronger position Customers With a focus on quality, At Patel Chem Specialities, we requirements. customer requirements. within the pharmaceutical technical expertise and deliver safe, compliant, and high- customer responsiveness, excipients space. quality excipients through rigorous 20+ 4 Market Responsiveness – 8 Enabling Customer Success – the Company has developed manufacturing and a strong focus Agile operations and Solutions designed to help capabilities to serve both on continuous innovation to meet Countries competitive pricing that enable customers maintain quality, evolving industry needs. us to respond effectively to efficiency and competitiveness changing market conditions. in a dynamic market. 4 ANNUAL REPORT FY2025-26 ANNUAL REPORT FY2025-26 5 Patel Chem Specialities Limited CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS Our Suite of Products Industries We Cater To 1 2 3 We manufacture a range of products in the Our products find applications across a diverse range of industries, including: pharmaceutical excipient segment, catering to diverse applications across the industry. Our portfolio combines quality standards Pharmaceuticals & Nutraceuticals Food & Beverages comparable with leading international products with competitive pricing, Disolwell – BlowTab – Sodium Swellcal – Calcium enabling us to deliver Croscarmellose Starch Glycolate Carboxymethyl strong value across Sodium (CCS) (SSG) Cellulose (Calcium Cosmetics & Personal Care Textiles applications. We continue A cross-linked cellulose-based A high-performance CMC) to develop new products superdisintegrant that promotes superdisintegrant used in A cellulose-based excipient within our existing rapid water uptake and tablet pharmaceutical formulations with disintegrating, binding and segments, including disintegration, supporting to facilitate rapid tablet and stabilising properties, primarily niche offerings designed consistent dissolution and drug capsule disintegration and used in pharmaceutical and for specific applications release. support effective release nutraceutical formulations. Paper Oil & Gas and tailored to customer of active pharmaceutical specifications. ingredients. 4 5 6 Agriculture & Agrochemicals Surfactants & Detergents Specialty Chemicals & Polymers Adhesives Rheollose – Sodium Hindcell – Sodium Monochloro Carboxymethyl Microcrystalline Acetate (SMCA) Cellulose (Sodium Cellulose (MCC) A key chemical intermediate Construction Mining CMC) A highly purified cellulose- used in the manufacture of A multifunctional cellulose based excipient widely used cellulose derivatives such derivative offering thickening, as a binder, diluent and bulking as CMC and SSG, as well as binding, stabilising and agent, supporting tablet pharmaceutical, agrochemical, emulsifying properties across strength, consistency and detergent and other specialty pharmaceutical, food and formulation performance. chemical applications. industrial formulations. Paints Ceramics 6 ANNUAL REPORT FY2025-26 ANNUAL REPORT FY2025-26 7 Patel Chem Specialities Limited CORPORATE OVERVIEW STATUTORY REPORT FINANCIAL STATEMENTS Our Journey of Progress 2008 2014 2016 2023 2025 Our journey reflects a commitment to building a Established with a focus on Obtained KOSHER certification, Obtained Halal certification Recognised as a Star Export Received USFDA certification/ pharmaceutical excipients. strengthening our ability to serve for [Showing first 8,000 characters — download PDF for full document]